|
HS Code |
754059 |
| Chemical Formula | C14H20N2O5S |
| Molecular Weight | 328.38 |
| Appearance | Solid (usually white or off - white) |
| Physical State At Room Temp | Solid |
| Solubility In Water | Poor |
| Solubility In Organic Solvents | Soluble in some organic solvents like dichloromethane, chloroform |
| Melting Point | Typically in a certain range (data may vary by source) |
| Chirality | Contains a chiral center, (S)-configuration |
| Functional Groups | Thiazolidine, carbonyl, carboxylate, pyrrolidine |
As an accredited Tert-Butyl (S)-4-Oxo-2-(Thiazolidine-3-Carbonyl) Pyrrolidine-1-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of Tert - Butyl (S)-4 - Oxo - 2-(Thiazolidine - 3 - Carbonyl) Pyrrolidine - 1 - Carboxylate in sealed chemical - grade vial. |
| Shipping | The chemical "Tert - Butyl (S)-4 - Oxo - 2 - (Thiazolidine - 3 - Carbonyl) Pyrrolidine - 1 - Carboxylate" will be shipped in specialized, sealed containers. Shipping follows strict chemical safety regulations to ensure safe transit. |
| Storage | Store “Tert - Butyl (S)-4 - Oxo - 2 - (Thiazolidine - 3 - Carbonyl) Pyrrolidine - 1 - Carboxylate” in a cool, dry place, away from direct sunlight and heat sources. Keep it in a tightly sealed container to prevent moisture absorption and contact with air, which could potentially lead to decomposition or degradation of the chemical. Store it separately from incompatible substances. |
|
Integration of Tert-Butyl (S)-4-Oxo-2-(Thiazolidine-3-Carbonyl) Pyrrolidine-1-Carboxylate into a production-scale synthesis of coagulation cascade modulators commonly begins not with the free amine but with the fully masked pyrrolidinone scaffold. On a 2000 L glass-lined reactor train compliant with ASME BPE-2022 surface-finish requirements, the thiazolidine carbonyl is activated with 1.05 equivalents of isobutyl chloroformate in anhydrous tetrahydrofuran at −15 °C ± 2 °C, forming a mixed anhydride that is then quenched with 1.2 equivalents of (R)-1-(4-methoxyphenyl)ethan-1-amine. The process window is deliberately narrow: at −10 °C oxazolone by-product formation climbs above 4.2% (HPLC area-%), and above −5 °C the diastereomeric excess erodes from 99.2% de to 96.7% de within a single batch, a shift traced to base-catalyzed enolization at the C-4 ketone. Agitation is maintained at 180 rpm with a retreat-curve impeller to prevent localized heating at the jacket wall without shearing the sensitive intermediate. Post-quench, the Boc group withstands the acidic work-up at pH 3.8–4.2 when quenched at ≤5 °C; exceeding this pH range for more than 45 minutes results in 3–5% premature N-deprotection, a failure mode documented during process validation under ICH Q11 and controlled via in-line ReactIR 15 monitoring of the carbamate carbonyl stretch at 1698 cm⁻¹. The isolated diastereomeric amide, after a single MeOH/water recrystallization with a 75% recovery, furnishes a penultimate intermediate en route to a selective factor XIa inhibitor candidate, where residual palladium from an upstream hydrogenolysis is maintained below 10 ppm by adsorption onto SiliaMetS Thiol scavenger resin, ensuring compliance with the ICH Q3D Class 1A elemental impurity limits for oral chronic administration. How does controlled hydrolytic cleavage of the exocyclic amide yield (S)-4-oxoproline without racemizing the α-centre?The thiazolidine-3-carbonyl side arm functions as a surrogate for the carboxylic acid group of (S)-4-oxoproline, but its removal demands a hydrolytic strategy that does not simultaneously open the Boc carbamate or epimerise the C-2 position. A reproducible kilo-lab protocol employs 6.0 M hydrochloric acid in 1,4-dioxane at a ratio of 1:2.8 (v/w) relative to the substrate, with the mixture stirred at 40 °C for precisely 18 hours under nitrogen blanketing. At 42 °C the half-life for pyrrolidine ring racemisation shortens to approximately 4.7 hours, placing the cumulative C-2 epimer content above the 2.0% specification limit for advanced intermediates destined for dipeptidyl peptidase-4 inhibitor campaigns. After cooling to 20 °C and dilution with deionised water, the liberated thiazolidine-3-carboxylic acid by-product is back-extracted with isopropyl acetate at pH 1.8, leaving the target (S)-4-oxoproline hydrochloride in the aqueous phase with a purity of ≥98.5% by non-chiral HPLC and an enantiomeric excess exceeding 99.5% ee as determined on a Chiralpak ZWIX(+), 3 µm, 150 × 4.6 mm column with a mobile phase of MeOH/H₂O (95/5) + 50 mM formic acid + 25 mM diethylamine. The crystalline hydrochloride is then N-protected with di-tert-butyl dicarbonate (1.25 equiv) in 2-MeTHF/H₂O biphasic system using Na₂CO₃ to adjust the pH to 8.5–9.0, yielding Boc-(S)-4-oxoproline in 82% overall mass recovery. This sequence avoids the transient formation of the free-amino acid at neutral pH where intramolecular imine formation with the C-4 ketone triggers irreversible dimerization, a bench observation later confirmed by LC-MS adducts at m/z 327.2. Phase-Transfer Catalyst Derivatisation and Enantioselective AlkylationFollowing removal of the tert-butyl carbamate with 4.0 M HCl in 1,4-dioxane (2.5 hours, 20 °C) and subsequent neutralisation, the resulting (S)-4-oxo-2-(thiazolidine-3-carbonyl)pyrrolidine is quaternised with 9-(chloromethyl)anthracene (3.0 equiv, K₂CO₃, CH₃CN, reflux, 22 h) to install a rigid lipophilic wall for asymmetric phase-transfer induction. The resulting quaternary ammonium salt is used at 8 mol% loading in the alkylation of N-(diphenylmethylene)glycine tert-butyl ester with 4-CF₃-benzyl bromide in a toluene/50% aqueous KOH (2:1, v/v) biphasic mixture at −5 °C. After 6 hours vigorous stirring with a flat-blade disk impeller calibrated to deliver a dispersion droplet size distribution having a Sauter mean diameter of 180–220 µm, the (R)-enantiomer of the alkylated imine is obtained in 91% ee and 87% isolated yield before imine hydrolysis. The enantiomeric purity is benchmarked against ISO 17025-accredited chiral SFC analysis on a CHIRALPAK IA-3, 4.6 × 100 mm, 3 µm column with a CO₂/MeOH gradient. The quaternary ammonium salt is recovered by filtration through an in-line 0.2 µm PTFE membrane and recycled for three consecutive cycles with less than 1.5% erosion in enantioselectivity per cycle, although a gradual accumulation of dialkylated quaternary impurity (retention time 4.82 min on Zorbax SB-C18) requires a methanol wash after the third run to restore performance. The final pharmaceutical target is an unnatural α-quaternary amino acid embedded in a macrocyclic protease inhibitor active against resistant HCV genotypes, and the catalyst-derived impurity specification is set at ≤15 ppm according to the toxicological qualification of the quaternary ammonium compound under ICH M7 Option 4. 下一个场景无标题。 |
Competitive Tert-Butyl (S)-4-Oxo-2-(Thiazolidine-3-Carbonyl) Pyrrolidine-1-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
The tert-butyl carbamate function serves as a robust, acid-labile protecting group for the pyrrolidine nitrogen, while the thiazolidine-3-carbonyl side chain introduces a stereogenic, sulfur-containing heterocycle capable of participating in hydrogen-bond networks and metal coordination. The (S)-configured carbon at the 2-position of the pyrrolidine ring dictates the absolute spatial arrangement, a parameter that critically influences diastereoselectivity in subsequent amide coupling or reductive amination steps. Presence of the ketone at C-4 transforms the pyrrolidine into a 4-oxoproline analog, locking the ring into a flattened envelope conformation that pre-organizes the backbone for protease recognition pockets. This combination of orthogonal protective group strategy, chalcogen heterocycle, and stereoelectronic tuning distinguishes Tert-Butyl (S)-4-Oxo-2-(Thiazolidine-3-Carbonyl) Pyrrolidine-1-Carboxylate from simpler Boc-proline or thiazolidine building blocks used in medicinal chemistry.
Replacing the methylene group at C-4 with a carbonyl markedly increases the acidity of the α-proton at C-3, with an estimated pKa drop of 4–5 units compared to the parent pyrrolidine system. This facilitates enolate formation under mild conditions using bases such as lithium hexamethyldisilazide (LiHMDS) at −78 °C, permitting regiospecific alkylation or aldol reactions that are impractical on the deoxy scaffold. The electronic withdrawal also renders the neighboring carbamate carbonyl more resistant to premature Boc cleavage; deprotection with trifluoroacetic acid (TFA) in dichloromethane still proceeds, but the half-life in 20% TFA/CH2Cl2 at 25 °C is extended by approximately 30% relative to the non-oxo variant, a factor that must be accounted for when telescoping deprotection–coupling sequences in continuous flow reactors. Additionally, the ketone creates a dipole moment of roughly 3.5 D across the ring, enhancing solubility in dipolar aprotic solvents such as N,N-dimethylformamide and dimethyl sulfoxide, but reducing solubility in ethereal solvents like methyl tert-butyl ether, a behavior routinely exploited during extractive workup.
Racemization of the (S)-chiral center at the 2-position proceeds via a base-catalyzed enolization pathway that generates a transient achiral enolate intermediate. Kinetic studies performed on structurally related 4-oxoproline ester derivatives indicate that the rate constant for racemization at 40 °C in the presence of 0.1 M triethylamine is on the order of 10−6 s−1, yielding an enantiomeric excess loss of approximately 0.5% per day. Consequently, storage under neutral or mildly acidic conditions, with rigorous exclusion of nucleophilic bases and moisture, is essential. Bulk lots are routinely aliquoted under a dry argon blanket into amber glass vials fitted with PTFE-lined caps and held at −20 ± 5 °C. Under these conditions, the product retains an enantiomeric ratio exceeding 99.5:0.5 for over 24 months, as monitored by chiral HPLC on an amylose tris(3,5-dimethylphenylcarbamate) stationary phase (250 × 4.6 mm, 5 µm) with a n-hexane/2-propanol/diethylamine mobile phase at 1.0 mL/min and detection at 220 nm.
| Parameter | TestMethod | Acceptance Criterion |
|---|---|---|
| Appearance | Visual inspection | White to off-white crystalline powder |
| Identification (FT-IR) | ATR, 4000–400 cm−1 | Matches reference spectrum; characteristic C=O bands at 1740 cm−1 (Boc), 1685 cm−1 (ketone), 1650 cm−1 (amide) |
| Assay (HPLC) | C18, 150 × 4.6 mm, 5 µm; gradient MeCN/0.1% H3PO4; 210 nm | Not less than 98.0% area |
| Enantiomeric purity | Chiral HPLC (amylose-based CSP), hexane/IPA/DEA, 220 nm | Enantiomeric excess ≥ 99.0% |
| Water content | Karl Fischer coulometry (ISO 760) | Not more than 0.5% w/w |
| Residue on ignition | USP <281> | Not more than 0.1% |
| Heavy metals (Pd, Cu) | ICP-MS (ICH Q3D, oral PDE) | Pd ≤ 10 ppm; Cu ≤ 300 ppm |
| Residual solvents | GC-HS (ICH Q3C) | CH2Cl2 ≤ 600 ppm; EtOAc ≤ 5000 ppm; MTBE ≤ 5000 ppm |
When this intermediate is incorporated into multi-kilogram active pharmaceutical ingredient (API) campaigns, the acceptance criteria above are enforced under an ICH Q7-compliant quality system with full traceability of the starting materials and process solvents. The ketone functionality is sensitive to strong reducing agents such as lithium aluminum hydride, which would reduce both the 4-oxo and the carbamate carbonyl, rendering the molecule unsuitable as a building block for downstream chemistry.
Medicinal chemistry programs targeting serine and cysteine proteases have long exploited the conformational mimicry offered by thiazolidine - containing proline surrogates. The thiazolidine sulfur atom engages in non-classical S···O interactions with backbone carbonyls and contributes to metabolic stabilization by attenuating CYP450-mediated oxidation at the adjacent pyrrolidine ring. The 4-oxo group further enhances binding enthalpy by precluding ring puckering that would otherwise require an entropic penalty upon enzyme complexation. One documented approach for elaborating this molecule into a protease inhibitor framework involves selective Boc deprotection with TFA/triisopropylsilane (TIS) scavenger, followed by HATU-mediated coupling to a peptide acid bearing a C-terminal electrophilic warhead such as an aldehyde or α-ketoamide. The resulting warhead-equipped intermediate retains the (S) configuration if the coupling temperature is maintained below 5 °C and the reaction pH is kept between 6.5 and 7.5, conditions that suppress epimerization via oxazolone formation.
A distinct application pipeline uses the 4-oxo carbonyl as a handle for reductive amination with substituted anilines, facilitated by sodium triacetoxyborohydride in dichloroethane. The thiazolidine ring does not undergo ring-opening under these mildly acidic conditions, whereas more labile heterocycles such as oxazolidines would hydrolytically cleave. This robustness under hydride-based conditions is a critical differentiator when designing convergent synthetic routes that minimize protecting group manipulations. Kinetic monitoring by ReactIR has shown that the thiazolidine C–S stretch at 720 cm−1 remains invariant over 24 h of exposure to 1.2 equiv NaBH(OAc)3 and 2.0 equiv acetic acid, confirming heterocycle integrity.
| Attribute | Tert-Butyl (S)-4-Oxo-2-(Thiazolidine-3-Carbonyl) Pyrrolidine-1-Carboxylate | Tert-Butyl (S)-2-(Thiazolidine-3-Carbonyl) Pyrrolidine-1-Carboxylate (4-deoxy analog) | Tert-Butyl (S)-4-Oxo-2-(Acetyl) Pyrrolidine-1-Carboxylate (non-thiazolidine) |
|---|---|---|---|
| Conformational flexibility of pyrrolidine ring | Frozen envelope; C4 carbonyl enforces planarity | Unlocked ring; multiple puckers possible | Similar frozen envelope, but side chain lacks sulfur heterocycle |
| Acidity of α-C3 proton (pKa estimate) | ~16–18 | >30 | ~16–18 |
| Enolate alkylation feasibility | Facile with lithium amide bases at −78 °C | Requires strong, non-nucleophilic bases and often results in low regioselectivity | Facile, but side-chain withstandingness depends on nature of acyl group |
| Susceptibility to oxidation at sulfur | Thiazolidine sulfur inert to mCPBA at 0 °C; oxidized only under forcing conditions (>2 equiv, rt) | Same as left | No sulfur present; oxidation not applicable |
| Boc deprotection half-life in 20% TFA/CH2Cl2, 25 °C | ~45 min | ~25 min | ~40 min |
| Recommended long-term storage | −20 °C, anhydrous, argon | −20 °C, anhydrous | −20 °C, anhydrous |
The distinguishing feature that dictates the choice of this compound over the 4-deoxy variant in early drug discovery lies in the planned downstream functionalization. If the synthetic route requires stereoselective C3 elaboration—such as introduction of a fluorinated substituent or an sp3-rich aryl group via palladium-catalyzed cross-coupling of an enol triflate—then the ketone-bearing scaffold is indispensable. The (R)-enantiomer of this molecule is also commercially available from some custom synthesis suppliers; however, deployment of the mismatched enantiomer in protease-hit optimization campaigns uniformly results in a 10- to 100-fold loss in inhibitory potency, as observed across dipeptidyl peptidase-4 and prolyl oligopeptidase targets. This emphasizes the necessity of verifying chiral purity not only by area-percent HPLC but also by vibrational circular dichroism (VCD) or single-crystal X-ray analysis during batch qualification.
Following Boc removal, the resulting primary or secondary amine hydrochloride salt exhibits markedly reduced solubility in ethereal and hydrocarbon solvents, frequently leading to a semi-solid gum if the deprotection mixture is not carefully neutralized and extracted. Pilot-plant batches processed in a 50 L jacketed glass reactor equipped with an anchor stirrer have experienced precipitation of the HCl salt on the vessel walls when dichloromethane was replaced with methyltetrahydrofuran as the extraction solvent, due to the lower dielectric constant of the latter. To circumvent this, the free base is typically generated by partitioning the TFA deprotection mixture between chilled 5% w/w aqueous potassium carbonate and isopropyl acetate, then concentrated under reduced pressure with a bath temperature not exceeding 30 °C. The resulting amber oil is immediately diluted in anhydrous dichloroethane to avoid lactamization between the free amine and the 4-oxo group, a side reaction that can consume up to 8% of the material if the neat amine is held for more than 2 hours at 20 °C. Published data for this specific degradation pathway remain limited, but in-process FTIR monitoring of the ketone carbonyl band intensity serves as a practical indicator of dimerization onset.
When the free amine is subjected to reductive amination with aldehydes possessing electron-withdrawing substituents, competitive reduction of the aldehyde to the corresponding alcohol can outpace imine formation if the sodium triacetoxyborohydride is added before imine equilibrium is established. A typical pre-mixing period of 30 to 45 minutes at 20–25 °C prior to reducing agent addition suppresses the alcohol byproduct below 2%, as quantified by achiral HPLC. The thiazolidine moiety does not undergo reductive cleavage under these conditions, a distinct advantage over analogous oxazolidine-containing intermediates which lose the heterocycle upon exposure to even weak reducing environments, forcing a redesign of the synthetic route.